Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023

Mark Bradley's Biography



Mark Bradley, Professor, Schools of Chemistry and Medicine, University of Edinburgh

Mark received his doctorate from the University of Oxford in 1989, followed by post-doctoral studies at Harvard and returning to the UK as a Royal Society University Research Fellow (University of Southampton). In 1997 he was made a Professor of Combinatorial Chemistry setting up the UK’s Centre for Combinatorial Chemistry. In 2005 he moved to the University of Edinburgh, where he is now Director of a £15M Interdisciplinary Research Collaboration in the area of Optical Molecular Imaging (Proteus 2014-2023). He is also PI on a Doctorial Training Centre (60PhD) in Optical Imaging with Entrepreneurship and holds an ERC advanced grant on “SmartMaterials” for cellular control. He has been elected to fellowships of the Royal Society of Edinburgh. In 2011 he was awarded the Chancellors Award – the highest research award of the University of Edinburgh. In 2012 he was awarded an honoree Professorship by Changzhou University, China. He is a co-founder of Ilika Technologies (2004) (which floated on AIMS in 2010), DestiNA Technologies (2010) and Edinburgh Molecular Imaging (2014).

Three research themes dominate in his group at this time:

(i). The development and exploitation of polymer-based technologies for the identification and application of polymers for controlling and modulating stem cells.

(ii). The development of “smart” fluorescent reporters for in vivo based optical molecular imaging.

(iii). In vivo catalytic chemistry

Mark Bradley Image

Optical Diagnostics for Bacterial Detection

Tuesday, 20 June 2023 at 16:00

Add to Calendar ▼2023-06-20 16:00:002023-06-20 17:00:00Europe/LondonOptical Diagnostics for Bacterial DetectionPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Over the past decade, we have designed and developed an entire palette of molecules containing targeting moieties (that specifically bind to Gram+ bacteria, Gram- bacteria and fungi) conjugated to a range of fluorophores to enable prompt and precise diagnosis of clinically relevant pathogens. I will describe these probes and explain how they have been used in a number of human systems including in vivo (in the human lung) and in eye and urinary tract infections. I will also describe a range of molecules that allow the binding and detection of bacterial infections and their subsequent elimination of infection following illumination.


Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com